EXELIXIS INC stock forecast: down to 22.38 USD EXEL stock price prognosis

STOCK

Forecast for Thu 20 Jun 2024 price 21.42

EXELIXIS INC stock price forecast for further price development down to -5.56% (time horizon: 1 day) and price target of 22.38 USD. Short-term (time horizon: 2 weeks) EXELIXIS INC share price prediction for 2024-06-20 with daily closed price projections

Key Facts

Symbol EXEL 

ISIN US30161Q1040 

CUSIP 30161Q104

Currency USD

Category Biological Products (No Diagnostic Substances)

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Revenue 1,030,853,000.0

Earnings per share 0.20

twitter facebook

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

For these types of cancer, cabozantinib has become or is becoming a standard of care. Prior to 2017, there was only one approved systemic therapy for the treatment of HCC. Approximately 5% to 15% of differentiated thyroid tumors are resistant to RAI treatment. "Locally Advanced or Metastatic Solid Tumors - COSMIC-021. Median PFS was 9.5 months (95% CI 5.5—NE), and median DOR was 8.3 months. CONTACT-02 is sponsored by us and co-funded by Roche. The trial aims to enroll approximately 500 patients at up to 167 sites globally. A summary of key ongoing trials under this collaboration is provided below. In addition, we are entitled to receive low double-digit royalties on sales of MINNEBRO. 8,877,776, 9,724,342, 10,034,873 and 10,039,757, which are listed in the Orange Book. The risks and uncertainties described below are not the only ones we face. Also, we may not have sufficient personnel to execute our business plans.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/939767/000162828021001852/0001628280-21-001852.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 39.06/100
    • Not in ideal financial position.
    • Historical view, profit is growing.
    • Company revenue is growing faster compared with the industry.
    • Stock price is above book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 416785
CGC Financial Services, LLC 2023-06-30 128
A - OSAIC HOLDINGS, INC. 2023-06-30 118337
China Universal Asset Management Co., Ltd. 2023-06-30 4268
VOYA INVESTMENT MANAGEMENT LLC 2022-09-30 351446

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Pacer Funds Trust 2023-07-31 56632 Long
Pacer Funds Trust 2023-07-31 3252 Long
Legg Mason Partners Investment Trust 2023-11-30 40105 Long
Voya Equity Trust 2023-11-30 37993 Long
Tema ETF Trust 2023-11-30 17959 Long

Insider trading for EXELIXIS INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1692954 Haley Patrick J. 2024-02-23 SALE Accept Accept Accept Accept
1648367 Senner Christopher J. 2023-08-03 SALE Accept Accept Reject Reject
1599803 Hessekiel Jeffrey 2023-12-13 SALE Accept Accept Accept Accept
1312907 Garber Alan M 2024-03-21 SALE Accept Accept Accept Accept
1727492 Caligan Partners Lp 2024-02-21 BUY Accept Accept Accept Accept
1959132 Aftab Dana 2023-08-30 SALE Accept Reject Accept Accept
Assets / Liabilities

Bollinger Bollinger Bands for EXELIXIS INC can provide the information where the market is moving based on price information.

EXELIXIS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns EXELIXIS INC.

On-Balance Volume information for EXELIXIS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for EXELIXIS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for EXELIXIS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for EXELIXIS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for EXELIXIS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for EXELIXIS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for EXELIXIS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

Moving Average Crossover

52W High 52W Low Market Cap

Similar shares

Trend:
chart
Ayala Pharmaceuticals, Inc

Trend:
chart
GRITSTONE ONCOLOGY INC

Trend:
chart
NOVAVAX INC

Trend:
chart
BRAINSTORM CELL THERAPEUTICS INC

EXELIXIS INC on Nasdaq

EXELIXIS INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-05-24 22.38 2024-04-25 13:24
2024-05-22 22.52 2024-04-25 13:24
2024-05-23 22.45 2024-04-25 13:24
2024-05-07 23.06 2024-04-25 13:24
2024-05-20 22.62 2024-04-25 13:24
2024-05-21 22.59 2024-04-25 13:24
2024-05-27 22.32 2024-04-25 13:24
2024-05-28 22.26 2024-04-25 13:24
2024-05-29 22.19 2024-04-25 13:24
2024-05-30 22.14 2024-04-25 13:24
2024-06-07 21.84 2024-04-25 13:24
2024-06-05 21.93 2024-04-25 13:24
2024-06-03 22.04 2024-04-25 13:24
2024-06-04 21.98 2024-04-25 13:24
2024-05-31 22.09 2024-04-25 13:24
2024-06-06 21.89 2024-04-25 13:24
2024-06-10 21.79 2024-04-25 13:24
2024-06-11 21.74 2024-04-25 13:24
2024-06-12 21.69 2024-04-25 13:24
2024-05-08 22.94 2024-04-25 13:24
2024-06-13 21.65 2024-04-25 13:24
2024-06-17 21.56 2024-04-25 13:24
2024-06-18 21.51 2024-04-25 13:24
2024-06-19 21.47 2024-04-25 13:24
2024-06-14 21.60 2024-04-25 13:24
2024-06-20 21.42 2024-04-25 13:25
2024-05-13 22.81 2024-04-25 13:24
2024-05-14 22.78 2024-04-25 13:24
2024-05-15 22.71 2024-04-25 13:24
2024-05-16 22.67 2024-04-25 13:24
2024-05-09 22.88 2024-04-25 13:24
2024-05-17 22.65 2024-04-25 13:24
2024-04-29 23.43 2024-04-25 13:24
2024-04-30 23.40 2024-04-25 13:24
2024-05-01 23.32 2024-04-25 13:24
2024-05-02 23.18 2024-04-25 13:24
2024-05-03 23.09 2024-04-25 13:24
2024-05-06 23.08 2024-04-25 13:24
2024-05-10 22.84 2024-04-25 13:24

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.